Literature DB >> 11822632

Comments on complementary and alternative medicine in Europe.

D Reilly1.   

Abstract

Despite the advances in Western medicine, up to one in three people in populations served by this medical system are seeking some form of unorthodox care each year, and Europe is no exception. Patients have driven this change, to the point where complementary and alternative medicine (CAM) is the second biggest growth industry in Europe. Often patients have to rely on the growing numbers of CAM practitioners with a variable standard of care that ranges from excellent to dangerous. Many practitioners work without regulation or even work illegally. Many orthodox health care professionals have shared their patients' concerns. Over the last 15 years, these practitioners have moved from silent interest to open enquiry and growing use. For example, approximately one in five of Scotland's general practitioners have received basic training in integrating homeopathy with orthodox practice. The demand for CAM is in part a search for a broader range of therapies, but is also a call for a different approach to care, with less emphasis on drugs, and a more whole-person approach. Mostly, people look to CAM when orthodoxy has failed. But CAM is also increasingly becoming a first-line intervention for some, because of the worry about the side effects of conventional treatments and a perception that orthodoxy has become dehumanized. With some exceptions, research is still in its early stages and lacks infrastructure. Patient satisfaction, empirical clinical outcome, and cost are beginning to be emphasized over mechanism of action or explanatory models. Recent official reports are calling for national and European-level enquiry and response. Future development is likely to emphasize integrative care. The challenge is to create better medical systems, with a whole-person emphasis, calling on a broader range of approaches than is currently orthodox. We seem to need a reunion of the art and science of medicine.

Entities:  

Mesh:

Year:  2001        PMID: 11822632     DOI: 10.1089/107555301753393779

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  7 in total

1.  Complementary and alternative medicine use in patients with hematological cancers in Malaysia.

Authors:  G G Gan; Y C Leong; P C Bee; E Chin; A K H Teh
Journal:  Support Care Cancer       Date:  2015-01-22       Impact factor: 3.603

2.  Use frequency of traditional Chinese medicine in Taiwan.

Authors:  Fang-Pey Chen; Tzeng-Ji Chen; Yen-Ying Kung; Yu-Chun Chen; Li-Fang Chou; Fan-Jou Chen; Shinn-Jang Hwang
Journal:  BMC Health Serv Res       Date:  2007-02-23       Impact factor: 2.655

3.  Homeopathy satisfaction in Iran.

Authors:  Ahmad Mahmoudian; Gholamhosein Sadri
Journal:  Iran J Nurs Midwifery Res       Date:  2014-09

4.  Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey.

Authors:  Massimiliano Berretta; Chiara Della Pepa; Paolo Tralongo; Alberto Fulvi; Ferdinando Martellotta; Arben Lleshi; Guglielmo Nasti; Rossella Fisichella; Carmela Romano; Chiara De Divitiis; Rosaria Taibi; Francesco Fiorica; Raffaele Di Francia; Anna Di Mari; Lino Del Pup; Anna Crispo; Paolo De Paoli; Adriano Santorelli; Vincenzo Quagliariello; Rosario Vincenzo Iaffaioli; Umberto Tirelli; Gaetano Facchini
Journal:  Oncotarget       Date:  2017-04-11

5.  An overview of the history and development of naturopathy in South Africa.

Authors:  Wendy G Ericksen-Pereira; Nicolette V Roman; Rina Swart
Journal:  Health SA       Date:  2018-07-31

6.  The potential of complementary and alternative medicine in promoting well-being and critical health literacy: a prospective, observational study of shiatsu.

Authors:  Andrew F Long
Journal:  BMC Complement Altern Med       Date:  2009-06-18       Impact factor: 3.659

7.  The use of CAM and conventional treatments among primary care consulters with chronic musculoskeletal pain.

Authors:  Majid Artus; Peter Croft; Martyn Lewis
Journal:  BMC Fam Pract       Date:  2007-05-04       Impact factor: 2.497

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.